• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液 LDL 胆固醇对老年人脑 Aβ 和 Tau 沉积相关性的调节作用。

Modulatory Effect of Blood LDL Cholesterol on the Association between Cerebral Aβ and Tau Deposition in Older Adults.

机构信息

Dong Young Lee, Department of Neuropsychiatry, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea; Telephone: +82-2-2072-2205, Fax: +82-2-744-2471, Email:

出版信息

J Prev Alzheimers Dis. 2024;11(6):1767-1774. doi: 10.14283/jpad.2024.131.

DOI:10.14283/jpad.2024.131
PMID:39559888
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11573824/
Abstract

BACKGROUND

This study investigates the synergistic relationship between blood low-density lipoprotein cholesterol (LDL-C) and cerebral beta-amyloid (Aβ) in relation to tau deposition, a key factor in the pathology of Alzheimer's disease (AD), in older adults across a diverse cognitive spectrum.

OBJECTIVES

To examine whether higher levels of LDL-C in the blood moderate the association of cerebral Aβ with tau deposition in older adults, including those with normal cognition, mild cognitive impairment, and Alzheimer's disease dementia.

DESIGN

Cross-sectional design.

SETTING

The study was conducted as a part of a prospective cohort study. All assessments were done at the Seoul National University Hospital, Seoul, South Korea.

PARTICIPANTS

A total of 136 older adults (aged 60-85 years) with normal cognition, mild cognitive impairment or Alzheimer's disease (AD) dementia were included.

MEASUREMENTS

Serum lipid measurements, [11C] Pittsburgh Compound B-positron emission tomography (PET), [18F] AV-1451 PET, and magnetic resonance imaging were performed on all participants.

RESULTS

There was a significant Aβ x LDL-C interaction effect on tau deposition indicating a synergistic moderation effect of LDL-C on the relationship between Aβ and tau deposition. Subsequent subgroup analysis showed that the positive association between Aβ and tau deposition was stronger in higher LDL-C group than in lower LDL-C group. In contrast, other lipids, such as total cholesterol, high-density lipoprotein cholesterol, and triglycerides, did not show a similar moderation effect on the relationship between Aβ deposition and tau deposition.

CONCLUSION

Our findings suggest that blood LDL-C synergistically enhances the influence of Aβ deposition on tau pathology, emphasizing the need for greater attention to the role of LDL-C in AD progression.

摘要

背景

本研究调查了血液中低密度脂蛋白胆固醇(LDL-C)与脑β-淀粉样蛋白(Aβ)之间的协同关系,以及它们与tau 沉积的关系,tau 沉积是阿尔茨海默病(AD)病理学中的一个关键因素,涉及认知范围广泛的老年人。

目的

研究血液中 LDL-C 水平是否会调节大脑 Aβ 与 tau 沉积在老年人中的关联,包括认知正常、轻度认知障碍和 AD 痴呆的老年人。

设计

横断面设计。

地点

本研究作为一项前瞻性队列研究的一部分进行。所有评估均在韩国首尔国立大学医院进行。

参与者

共纳入 136 名年龄在 60-85 岁之间认知正常、轻度认知障碍或 AD 痴呆的老年人。

测量

对所有参与者进行血清脂质测量、[11C]匹兹堡复合物 B-正电子发射断层扫描(PET)、[18F] AV-1451 PET 和磁共振成像。

结果

tau 沉积存在 Aβ x LDL-C 交互作用效应,表明 LDL-C 对 Aβ 和 tau 沉积之间关系具有协同调节作用。随后的亚组分析表明,Aβ 与 tau 沉积之间的正相关在 LDL-C 较高的组中比在 LDL-C 较低的组中更强。相比之下,其他脂质,如总胆固醇、高密度脂蛋白胆固醇和甘油三酯,对 Aβ 沉积与 tau 沉积之间的关系没有类似的调节作用。

结论

我们的研究结果表明,血液 LDL-C 协同增强了 Aβ 沉积对 tau 病理学的影响,强调需要更加关注 LDL-C 在 AD 进展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7542/11573824/85d405eebea0/42414_2024_131_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7542/11573824/85d405eebea0/42414_2024_131_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7542/11573824/85d405eebea0/42414_2024_131_Fig1_HTML.jpg

相似文献

1
Modulatory Effect of Blood LDL Cholesterol on the Association between Cerebral Aβ and Tau Deposition in Older Adults.血液 LDL 胆固醇对老年人脑 Aβ 和 Tau 沉积相关性的调节作用。
J Prev Alzheimers Dis. 2024;11(6):1767-1774. doi: 10.14283/jpad.2024.131.
2
Moderation of thyroid hormones for the relationship between amyloid and tau pathology.调节甲状腺激素对淀粉样蛋白和tau 病理的关系。
Alzheimers Res Ther. 2024 Jul 23;16(1):164. doi: 10.1186/s13195-024-01534-4.
3
Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology.高血压与脑β淀粉样蛋白对 tau 病理学的协同作用。
Alzheimers Res Ther. 2022 Dec 24;14(1):193. doi: 10.1186/s13195-022-01149-7.
4
Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study.适量饮酒与人体内淀粉样蛋白-β沉积的关系:一项横断面研究。
PLoS Med. 2020 Feb 25;17(2):e1003022. doi: 10.1371/journal.pmed.1003022. eCollection 2020 Feb.
5
Plasma Leptin and Alzheimer Protein Pathologies Among Older Adults.老年人血浆瘦素与阿尔茨海默病蛋白质病理学
JAMA Netw Open. 2024 May 1;7(5):e249539. doi: 10.1001/jamanetworkopen.2024.9539.
6
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.淀粉样蛋白和 Tau 预测认知和功能下降在认知正常的老年人:来自 A4 和 LEARN 研究的纵向数据。
J Prev Alzheimers Dis. 2024;11(4):802-813. doi: 10.14283/jpad.2024.122.
7
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
8
Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition.血浆神经丝轻链升高与阿尔茨海默病特征区域的多模态神经影像学特征相关,并可预测未来的tau 沉积。
BMC Neurol. 2024 Jul 6;24(1):236. doi: 10.1186/s12883-024-03728-7.
9
Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.临床诊断为阿尔茨海默病患者的脑淀粉样蛋白-β沉积与血液生物标志物。
J Alzheimers Dis. 2019;69(1):169-178. doi: 10.3233/JAD-190056.
10
Alzheimer's pathology targets distinct memory networks in the ageing brain.阿尔茨海默病病理改变靶向衰老大脑中的特定记忆网络。
Brain. 2019 Aug 1;142(8):2492-2509. doi: 10.1093/brain/awz154.

本文引用的文献

1
Cardiovascular disease, associated risk factors, and risk of dementia: An umbrella review of meta-analyses.心血管疾病、相关危险因素与痴呆风险:一项荟萃分析的伞状综述
Front Epidemiol. 2023 Feb 9;3:1095236. doi: 10.3389/fepid.2023.1095236. eCollection 2023.
2
Social determinants and lifestyle factors for brain health: implications for risk reduction of cognitive decline and dementia.社会决定因素和生活方式因素对大脑健康的影响:降低认知能力下降和痴呆风险的意义。
Sci Rep. 2022 Jul 28;12(1):12965. doi: 10.1038/s41598-022-16771-6.
3
Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies.
他汀类药物的使用与痴呆症或阿尔茨海默病风险:观察性研究的系统评价和荟萃分析
Eur J Prev Cardiol. 2022 May 5;29(5):804-814. doi: 10.1093/eurjpc/zwab208.
4
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.载脂蛋白 B 是阿尔茨海默病中早期 tau 病理学的新型标志物。
Alzheimers Dement. 2022 May;18(5):875-887. doi: 10.1002/alz.12442. Epub 2021 Sep 29.
5
ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease.载脂蛋白 E4 引起的胆固醇失调及其在阿尔茨海默病发病机制中的特定脑细胞类型影响。
Mol Cells. 2019 Nov 30;42(11):739-746. doi: 10.14348/molcells.2019.0200.
6
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Atherosclerosis. 2019 Nov;290:140-205. doi: 10.1016/j.atherosclerosis.2019.08.014. Epub 2019 Aug 31.
7
Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.早发性阿尔茨海默病与低密度脂蛋白胆固醇水平升高及 APOB 罕见遗传编码变异的关联。
JAMA Neurol. 2019 Jul 1;76(7):809-817. doi: 10.1001/jamaneurol.2019.0648.
8
ApoB, small-dense LDL-C, Lp(a), LpPLA activity, and cognitive change.载脂蛋白 B、小而密 LDL-C、脂蛋白(a)、脂蛋白相关磷脂酶 A 活性与认知改变。
Neurology. 2019 May 28;92(22):e2580-e2593. doi: 10.1212/WNL.0000000000007574. Epub 2019 May 1.
9
Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease.血浆 tau/淀粉样蛋白-β1-42 比值可预测阿尔茨海默病患者的脑 tau 沉积和神经退行性变。
Brain. 2019 Mar 1;142(3):771-786. doi: 10.1093/brain/awy347.
10
Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?tau 与神经炎症:对阿尔茨海默病和 tau 病有何影响?
Biomed J. 2018 Feb;41(1):21-33. doi: 10.1016/j.bj.2018.01.003. Epub 2018 Mar 20.